The Antibody Contract Manufacturing Global Market Report 2023, provides comprehensive information on the antibody contract manufacturing market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Antibody Contract Manufacturing Market’s Growth:
https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report
As per The Business Research Company’s Antibody Contract Manufacturing Global Market Report 2023, the global antibody contract manufacturing market is expected to grow from $11.18 billion in 2022 to $12.84 billion in 2023 at a compound annual growth rate (CAGR) of 14.82%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The antibody contract manufacturing market is expected to reach $21.79 billion in 2027 at a CAGR of 14.13%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12665&type=smp
Technological advancements are a key trend gaining popularity in the antibody contract manufacturing market. Major companies operating in the antibody contract manufacturing market are adopting new technologies to sustain their position in the market. For instance, in October 2021, Merck KGaA, a Germany-based science and technology company, introduced ChetoSensar, an innovative technology aimed at addressing solubility challenges in antibody-drug conjugates (ADCs). Merck KGaA intends to leverage their expertise in contract development manufacturing for the development of next-generation antibody-drug conjugates and improve the effectiveness of high-potency active pharmaceutical ingredients (HPAPIs) by enhancing the solubility of these compounds through the innovative ChetoSensar technology.
The antibody contract manufacturing market is segmented:
1) By Product: Monoclonal Antibodies, Polyclonal Antibodies, Other Products
2) By Source: Mammalian, Microbial
3) Scale Of Operation: Preclinical, Clinical, Commercial
4) By End-User: Biopharmaceutical Companies, Research Laboratories, Other End Users
Top 5 Major Players:
- AbbVie Inc
- Thermo Fisher Scientific Inc
- Boehringer Ingelheim Biopharmaceuticals GmbH
- Fujifilm Holdings Corporation
- Eurofins Scientific SE
North America was the largest region in the antibody contract manufacturing market in 2022.
Table of contents :
1. Executive Summary
2. Antibody Contract Manufacturing Market Characteristics
3. Antibody Contract Manufacturing Market Trends And Strategies
4. Antibody Contract Manufacturing Market – Macro Economic Scenario
5. Global Antibody Contract Manufacturing Market Size and Growth
……
32. Global Antibody Contract Manufacturing Market Competitive Benchmarking
33. Global Antibody Contract Manufacturing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Antibody Contract Manufacturing Market
35. Antibody Contract Manufacturing Market Future Outlook and Potential Analysis
36. Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Antibody Contract Manufacturing Market, Segmentation Scale Of Operation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
….
Table 75: AbbVie Inc. Financial Performance
Table 76: Thermo Fisher Scientific Inc. Financial Performance
Table 77: Boehringer Ingelheim Biopharmaceuticals GmbH Financial Performance
Table 78: Fujifilm Holdings Corporation Financial Performance
Table 79: Eurofins Scientific SE Financial Performance
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Related Reports:
https://topprnews.com/prostate-cancer-diagnostics-market-size/
https://topprnews.com/miticides-for-fruits-and-vegetables-market-size/
https://topprnews.com/global-advanced-drug-delivery-systems-market-size/
https://goodprnews.com/prostate-cancer-diagnostics-market-size/
https://goodprnews.com/miticides-for-fruits-and-vegetables-market-size/
https://goodprnews.com/global-advanced-drug-delivery-systems-market-size/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
